Table 3.
Most relevant DEG discrepancies between Oncopig and human cells in response to gemcitabine treatment.
Cellular Process | GENE | Function | Human | Oncopig |
---|---|---|---|---|
Apoptosis | Caspase 3 | Execution of apoptosis | Up | No difference |
Apoptosis | Caspase 10 | Execution of apoptosis | Up | No difference |
Apoptosis | CASP8AP2 | Regulatory role in Fas-mediated apoptosis | Up | No difference |
Apoptosis | TP73 | Member of the P53 family of transcription factor. Apoptosis response to DNA damage | Up | No difference |
Apoptosis | TP53 | Tumor suppressor gene. Apoptosis response to DNA damage | Down | No difference |
Apoptosis | FAS | Member of the TNF-receptor superfamily. Physiological regulation of programmed cell death | Up | No difference |
Apoptosis | Rb1 | Tumor suppressor gene. Negative regulator of the cell cycle | Up | No difference |
Apoptosis | MDM4 | Inhibits Tp53 and Tp73-mediated cell cycle arrest and apoptosis | No difference | Up |
Differences in expression are expressed as changes in treated compared to control groups (cells exposed only to medium).